| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |